Alpha Thalassemia Major
Phase 1 Clinical Trial: In Utero Hematopoietic Stem Cell Transplantation for ATM
UCSF Fetal Treatment Center
Dedicated to research and innovation in diagnosis and treatment
Multidisciplinary Approach
All the members of our multidisciplinary Fetal Treatment Center (FTC) team play an integral role in your care. The team includes clinicians involved in the direct care of patients as well as research fellows who are developing novel therapies in diagnosis and treatment of the fetus. Our team meets weekly to discuss your care, patient outcomes, birth results, and — equally important — to share recent research which ultimately may result in even more effective fetal interventions.
Fetal Research
Leaders in genomics and precision-based in utero diagnosis and care
Fetal Exome Sequencing
Better fetal diagnosis and treatment through next-generation gene sequencing
Fetal Heart & Brain Study
Studying how congenital heart disease affects fetal brain development
HyDROPS
A precision-based approach to care for Non-Immune Hydrops Fetalis
In Utero Enzyme Replacement Therapy
Phase 1 Clinical Trial: In Utero Enzyme Replacement Therapy (ERT) for Fetuses with Lysosomal Storage Diseases (LSDs)
RAFT Trial
Fetal intervention trial for bilateral renal agenesis and fetal renal failure
MedConnection Videos
Resources from leading medical experts from UCSF Fetal Treatment Center
Congenital Heart Disease: The Value and Future of Fetal Screening
With CHD often discovered in low-risk pregnancies and associated with neurodevelopmental deficits, the need for more screening and advanced techniques is clear.
The Potential of Fetal MRI: Delivering Value Now and in the Future
UCSF pediatric radiology specialists address fetal MRI safety concerns and explain when to consider advanced imaging.
Hard Facts to Inform Hard Decisions: Treating the Fetal Heart
Anita J. Moon-Grady, MD, FAAP, director of the UCSF Fetal Cardiovascular Program, examines the reality of whether long-term outcomes are better for babies who had in utero interventions for certain heart defects, as well as the short-term.
Genetic Diseases Linked to Nonimmune Hydrops: Distinctions in Diagnosis and Prognosis
In this short video, Maternal-Fetal Medicine and Genetics specialist, Dr. Teresa Sparks, MD, MAS, presents a recently published UCSF study of non-immune hydrops fetalis (NIHF) cases.
Placenta Accreta Spectrum Disorder: Proven Strategies from a Multidisciplinary Team
Placenta accreta spectrum disorder is a varied and increasingly common complication of pregnancy, so ob/gyns need a firm grasp of risk factors and ultrasound signs